ClinicalTrials.Veeva

Menu

Hypnosis for Treating Xerostomia Following Radiotherapy in Head & Neck Cancer Patients

B

Bnai Zion Medical Center

Status and phase

Unknown
Phase 2

Conditions

Xerostomia

Treatments

Behavioral: hypnosis

Study type

Interventional

Funder types

Other

Identifiers

NCT00408759
eschiff

Details and patient eligibility

About

xerostomia develops in all patients with head and neck cancer following radiotherapy. it consists one of the main side effects which affects quality of life. currently, there is no standard of care for treating this condition. parasympathomimetic drugs may help but carry significant side effects.

hypnosis may affect autonomic function such as salivation, in healthy people.in this study we will explore the efficacy of hypnosis in improving salivation, in the patient population.

Full description

10 head and neck cancer patients with xerostomia following radiotherapy will be assessed for severity of xerostomia using questionnares and quantitative salivation tests. patients responsive to citric acid will receive a hypnotic session with specific suggestion for salivation. saliva volume will be assessed pre and post hypnosis. patients will receive a CD with recorded hypnotic session to use freely at home. xerostomia will be assessed using a questionnare one week following hypnosis.

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • radiotherapy for head and neck cancer
  • xerostomia

Exclusion criteria

  • psychiatric illness (present or past)

Trial design

Primary purpose

Treatment

Allocation

Non-Randomized

Interventional model

Single Group Assignment

Masking

None (Open label)

Trial contacts and locations

1

Loading...

Central trial contact

elad schiff; gorge mogilner

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems